11/26/2008
Federal Register Notice: FDA’s proposed collection of information, Prescription Drug Product Labeling: Medication Guide Requ...11/26/2008
Federal Register Notice: FDA is seeking comments on a study examining the impact on consumer comprehension of inclusion of a toll-...11/26/2008
Federal Register Notice: FDA and AdvaMed are co-sponsoring a public workshop 12/9, “Sex Differences in the Cardiovascular De...11/21/2008
Federal Register Notice: FDA’s Oncologic Drugs Advisory Committee will meet 12/16, from 8 a.m. to 4 p.m. at the Hilton Washi...11/21/2008
Federal Register Notice: FDA has determined that Nubain (nalbuphine hydrochloride) injection, 10 and 20 mg/ml, was not withdrawn f...11/17/2008
Federal Register Notice: FDA seeks comments on reprocessed single-use device labeling, “Compliance With Section 301 of the M...11/17/2008
Federal Register Notice: FDA has determined the regulatory review period for Somatuline Depot is 3,629 days for extending a patent...10/20/2008
Federal Register Notice: FDA is making available a draft guidance, Tropical Disease Priority Review Vouchers. It explains to stake...